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Rationale: Heart failure (HF) claims 250,000 lives per year in the US, and nearly half of these deaths are 29 
sudden and presumably due to ventricular tachyarrhythmias. QT interval and action potential (AP) 30 
prolongation is a hallmark proarrhythmic change in the failing myocardium, which potentially results 31 
from alterations in repolarizing potassium currents. Thus, we aimed to examine whether decreased 32 
expression of the rapid delayed rectifier potassium current, IKr, contributes to repolarization 33 
abnormalities in human HF. To map functional IKr expression across the left ventricle (LV), we optically 34 
imaged coronary-perfused LV free wall from donor and end-stage failing human hearts. The LV wedge 35 
preparation was used to examine transmural AP durations at 80% repolarization (APD80), and treatment 36 
with the IKr-blocking drug, E-4031, was used to interrogate functional expression. We assessed the 37 
percent change in APD80 post-IKr blockade relative to baseline APD80 (∆APD80) and found that ∆APD80s 38 
are reduced in failing versus donor hearts in each transmural region, with 0.35-, 0.43-, and 0.41-fold 39 
reductions in endo-, mid-, and epicardium, respectively (p=0.008, 0.037, and 0.022). We then assessed 40 
hERG1 isoform gene and protein expression levels using qPCR and Western blot. While we did not 41 
observe differences in hERG1a or hERG1b gene expression between donor and failing hearts, we found 42 
reductions in hERG1a mature protein and a shift in the hERG1a:hERG1b isoform stoichiometry. 43 
Computer simulations were then conducted to assess IKr block under E-4031 influence in failing and 44 
nonfailing conditions. Our results confirmed the experimental observations and E-4031-induced relative 45 
APD80 prolongation was greater in normal conditions than in failing conditions, provided that the 46 
cellular model of HF included a significant downregulation of IKr. 47 
Conclusions: In human HF, the response to IKr blockade is diminished, suggesting decreased functional IKr 48 
expression This reduced functional response is associated with altered hERG1a:hERG1b protein 49 
stoichiometry in the failing human LV, and failing cardiomyoctye simulations support experimental 50 
findings. Thus, IKr protein and functional expression may be important determinants of repolarization 51 
remodeling in the failing human LV. 52 
 53 




AP=Action Potential; APD=Action Potential Duration; APD80=Action Potential Duration at 80% 57 
Repolarization; D=Donor; Endo=Endocardium; Epi=Epicardium; HF=Heart Failure; F=Failing; LV=Left 58 




Heart failure (HF) is the end stage of many cardiovascular diseases, in which the heart can no longer 63 
support the metabolic demands of the body. HF is an increasing problem in the US, with an estimated 5 64 
million Americans currently afflicted by the disease. Approximately ¼ million HF-related deaths occur 65 
annually,[1] nearly half of which are due to sudden cardiac death. These sudden cardiac events are 66 
presumably the result of ventricular tachyarrhythmias, which are a consequence of adverse 67 
electrophysiologic remodeling during the HF progression. 68 
Action potential (AP) prolongation and resulting QT prolongation are hallmark arrhythmogenic 69 
changes in the failing myocardium.[2-5] While increased late sodium current has been demonstrated in 70 
association with AP prolongation in HF,[6-8] voltage-dependent potassium currents are critical 71 
determinants of cardiac AP duration (APD). In humans, the rapid component of the delayed rectifier 72 
potassium current (IKr) is largely responsible for ventricular repolarization. Tetramers of the hERG1 73 
protein α-subunit, encoded by the KCNH2 gene, form the channel underlying cardiac IKr. Two different 74 
splice variants of KCNH2, both hERG1a and hERG1b, are expressed in human ventricular tissue, with the 75 
hERG1a isoform predominating.[9] In various animal models of HF, delayed rectifier potassium currents 76 
are reduced. However, in human isolated cardiomyocytes, IKr amplitude is small, making differences 77 
between donor and failing hearts undetectable.[2] 78 
We hypothesized that IKr is downregulated in human HF, promoting AP prolongation in failing 79 
myocardial tissue. Thus, we aimed to investigate functional IKr expression in the failing human left 80 
ventricle (LV) and examine the relative expression of hERG1a and hERG1b isoforms at the gene and 81 
protein expression levels. We then conducted cellular and fiber simulation studies to provide further 82 
evidence for IKr downregulation in HF. The regulation of functional IKr in human HF has not been 83 
previously reported; thus, these studies may help elucidate the underpinnings of arrhythmogenic AP 84 
prolongation in the failing human heart. 85 
 86 
Materials and Methods 87 
 88 
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Human heart recovery. All studies using human heart tissue have been approved by the Institutional 89 
Review Board at Washington University in St. Louis. In total for this study, we recovered 16 donor 90 
human hearts, rejected for transplantation from the Mid America Transplant Services (St. Louis, MO), 91 
and 14 end-stage failing hearts from transplant recipients at Barnes-Jewish Hospital. All hearts were 92 
obtained immediately after removal from the chest in the operating room. Hearts were arrested using 93 
ice-cold cardioplegic solution and transported to the laboratory for dissection and functional 94 
experiments. Prior to experiments, LV tissue was collected and preserved in RNA later (Sigma-Aldrich, St. 95 
Louis, MO) for mRNA or flash-frozen in liquid nitrogen for protein expression analyses. 96 
 97 
Optical imaging. Human LV wedge preparations were used for electrophysiologic experiments, as 98 
described previously.[3] Briefly, wedges were dissected from an LV marginal branch and were mounted 99 
with the transmural surface facing the optical apparatus (Figure 1A-B). Preparations were perfused with 100 
oxygenated Tyrode’s solution maintained at 37°C, with a perfusion pressure of 60-80 mmHg. 101 
Blebbistatin (10-20 μM) was used to immobilize myocardial tissue, and Di-4-ANEPPS was used to map 102 
transmembrane potential. Pseudo-ECGs were recorded with Ag/AgCl electrodes placed on either side of 103 
the transmural surface, and human intracellular APDs were validated using fixed 3.0 M KCl filled 104 
microelectrodes. Tissue was paced using a steady state S1S1 restitution protocol, starting at a pacing 105 
cycle length (CL) of 2,000 ms and progressively decreasing to the functional refractory period. Data were 106 
analyzed using custom-written MATLAB software.[10] Table 1 shows donor and patient characteristics 107 
of hearts used in functional experiments. 108 
 109 
Pharmacologic interrogation of IKr. Following the collection of baseline restitution measurements, we 110 
added 1 μM E-4031, a high-affinity IKr blocker, to the Tyrode’s solution. Recordings were collected at 5-111 
minute intervals after drug treatment, until a steady-state AP morphology was achieved (approximately 112 
15-20 minutes). The steady state restitution protocol was then repeated (Figure 1C). Because E-4031 113 




RNA isolation and real-time qPCR. Total RNA was extracted from human LV tissue samples using the 117 
RNEasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA), and RNA yield was quantified and purity assessed 118 
using the Nandrop 1000 (Thermo Scientific), as previously described.[11] Total RNA (1-2 ug) was 119 
converted to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 120 
City, CA). Real-time PCR of cDNA was performed with the TaqMan PCR Master Mix on a StepOnePlus 121 
sequence detector (Applied Biosystems, Foster City, CA). The RPL32 TaqMan Gene Expression Assay 122 
Hs00851655_g1 was used as an endogenous control, because it is one of the most stable reference 123 
genes for cardiac gene expression studies.[12] The TaqMan Gene Expression Assay Hs00165120_m1 was 124 
used to detect hERG1a mRNA, and custom-made assays were used for the detection of hERG1b, as 125 
previously described.[12] Data were analyzed using the threshold cycle (Ct) relative quantification 126 
method.[11, 13]  127 
 128 
Protein expression. Western blot analysis was performed on LV protein lysates, as previously 129 
described.[3, 4] Fresh endocardial and epicardial tissues were frozen in liquid nitrogen, pulverized, and 130 
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homogenized in super RIPA buffer. Protein was quantified using the BCA Assay (Bio-Rad, Hercules, CA), 131 
and equal protein masses were loaded for each sample. SDS-PAGE was carried out using standard 132 
methods, and membranes were probed with anti-Kv11.1 antibodies (Alomone, Israel, Jerusalem; Enzo 133 
Life Sciences, Farmingdale, NY). Images were acquired with the LAS-4000 mini (Fujifilm, Tokyo, Japan) 134 
and analyzed with Multi Gauge software (Fujifilm, Tokyo, Japan). Protein band densities were 135 
normalized to GAPDH.  136 
 137 
Statistical analysis. Statistical significance was determined by Student's t-test or Welch's t-test. Both 138 
one- and two-tailed t-tests were used as appropriate, depending on the whether our experimental 139 
prediction indicated a unidirectional change or that the alteration may have occurred in either direction. 140 
Paired t-tests were used to compare the same hearts before and after drug treatment, and unpaired 141 
tests were used to analyze donor and failing heart groups. The Welch’s t-test was selected when a 142 
statistically significant p value from f-test (p < 0.05) indicated unequal variance between groups. 143 
 144 
Human ventricular cell AP modeling. Simulations of endocardial and epicardial cell electrophysiological 145 
activity were carried out using one of the most up-to-date human ventricular myocyte models 146 
developed by Grandi et al.[14] (GPB model), which was characterized by a thorough description of 147 
intracellular calcium handling. Both cellular and one-dimensional strand simulations were performed, 148 
and we computed APD at 80% repolarization (APD80). A steady state S1S1 restitution protocol was 149 
simulated, starting at a pacing cycle length (CL) of 2,000 ms and decreasing to the functional refractory 150 
period. Computational methods are detailed in the Supplementary Materials. 151 
 152 
Homogeneous electrophysiological remodeling in HF. To simulate the electrical activity of human failing 153 
ventricular myocytes, the GPB model was modified as in Trenor et al.[15] Ionic parameters were 154 
changed to describe the hallmark characteristics of failing cardiac tissues and cells, such as AP 155 
prolongation and alterations of calcium handling, on the basis of experimental data (see Table 2 for 156 
details). To model downregulation of IKr, we gradually decreased this current up to 90% in different 157 
simulations. 158 
 159 
Heterogeneous electrophysiological remodeling in HF. Experimental studies describing transmural ion 160 
channel expression changes are insufficient from the failing human heart, and most of these studies 161 
have been limited to mRNA or protein level investigation.[11, 16-18] Furthermore, extrapolating gene or 162 
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protein expression to channel functional activity is not trivial. Thus, on the basis of the limited literature, 163 
we included a heterogeneous model of HF based on Gomez et al., where certain parameters were 164 
selectively altered in epicardial and endocardial cells.[19] Specifically, the activity of the Na+/Ca2+ 165 
exchanger (INCX), which shows a significant upregulation in failing myocytes, was increased 2-fold in 166 
epicardial cells and 1.6-fold in endocardial cells.[18, 20-22] As reported in our experiments, IKr was also 167 
decreased heterogeneously in endocardium (50% reduction) and epicardium (60% reduction) in strand 168 




APD Restitution with IKr blockade. To examine transmural effects of IKr expression in the human LV, we 173 
measured optical APs before and after treatment with E-4031. We then analyzed APD80 for each 174 
transmural region and constructed APD80 restitution curves by plotting the APD80 duration against the 175 
pacing cycle length (PCL) for donor and failing hearts. Baseline APD80 restitution curves for donor hearts 176 
(Figure 2A) reveal greater transmural dispersion of APD80s and shorter APs compared with failing hearts 177 
(Figure 2B). The longer APs in the failing heart are more pronounced at lower pacing frequencies, 178 
leading to steeper restitution curves. In contrast, following E-4031 treatment, APD80s for failing hearts 179 
(Figure 2E) are shorter than those for donor hearts (Figure 2D) at each pacing cycle length and 180 
restitution curves for failing hearts appear flattened (Figure 2B). APD80 gradients were then calculated 181 
at several PCLs by subtracting APD80Endo-APD80Epi. Transmural dispersion of APD80s was observed for 182 
donor hearts without and with E-4031, but not for failing hearts under either condition (Figure 2C,F). In 183 
addition, the donor heart APD80 gradients demonstrated a linear relationship with PCL (R2 = 0.92, p = 184 
0.003 for baseline; R2 = 0.78, p = 0.02 for E-4031), while no relationship was observed between failing 185 




Functional IKr expression. To assess functional, cell-surface expression of IKr, we examined APD80 189 
prolongation following E-4031 treatment. Figure 3A,B shows APD80 maps for representative donor and 190 
failing human hearts, respectively, at 1000 ms PCL. Corresponding pseudo-ECG recordings and optical 191 
recording traces are shown below each map. APD80 maps for the donor heart show the normal APD 192 
gradient from endo- to epicardium, and significant prolongation of the APD in each transmural region 193 
with IKr blockade. Conversely, the transmural distribution of APD80 are more uniform in the failing heart 194 
under control conditions, consistent with our previous reports.[3, 23] However, the effect of IKr blockade 195 




The distribution of APD80s is varied between donor and failing hearts without and with IKr blockade. 199 
Figure 3C,D show APD80 Gaussian distribution curves computed from the means and pooled standard 200 
deviations for donor and failing hearts. The distribution curves demonstrate greater separation between 201 
the pre- and post-E-4031 conditions for donor hearts compared with failing hearts. This widening 202 
between curves is due to the higher baseline APD80s in failing hearts, but even more so from increased 203 
APD80s in donor hearts following IKr blockade. Figure 3E shows average APD80 values for donor and 204 
failing hearts under control conditions and with E-4031 treatment (PCLs = 1,000 ms). IKr blockade in 205 
donor hearts results in strongly significant (p < 0.01) increases in APD80 in each transmural region; 206 
however, while IKr blockade still leads to transmurally increased APD80s for failing hearts, the 207 
differences are less significant (p < 0.05). In addition, we calculated the % change in APD80 after E-4031 208 
treatment relative to the control condition, or ΔAPD80 = [(APD80E-4031-APD80Control)/APD80Control]*100, 209 
which are greater in the donor hearts for each transmural region. ΔAPD80 values for failing versus donor 210 
hearts demonstrate 0.43-, 0.40-, and 0.45-fold reductions in endo-, mid-, and epicardium, respectively 211 
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(p=0.020, p=0.033, p=0.013, Figure 3F). Results obtained at the 2,000 ms PCL were consistent with the 1 212 
Hz data and are displayed in Figure S1. 213 
 214 
KCNH2 Gene Expression. To examine whether transcriptional regulation of hERG1a and hERG1b splice 215 
variants is responsible for the reduced effect of E-4031 in failing hearts, we analyzed the mRNA 216 
expression of both variants in human LV tissue samples. Figure 4A,B show relative quantification values 217 
of hERG1a and hERG1b in donor and failing LV samples. We found no statistically significant differences 218 
in the mRNA expression levels when comparing failing to donor human heart tissue (p = 0.84 and p = 219 
0.36, respectively). Although, hERG1b appears reduced in F, the variance for hERG1b donor gene 220 
expression is large. The majority of the apparent difference in hERG1b expression was due to a single 221 
sample, which was not excluded by Grubb’s analysis. These results suggest that decreased functional IKr 222 
in HF is not due to altered KCNH2 gene expression or splicing. 223 
 224 
hERG1 Protein Expression. Given that post-translational protein processing regulates functional ion 225 
channel expression, we then investigated whether altered hERG1 protein expression was associated 226 
with functional IKr downregulation. To do this, we examined hERG1a and hERG1b protein expression 227 
levels in endo- and epicardial LV samples. We observed that normalized hERG1a mature protein had a 228 
0.55-fold reduction (p = 0.51) in the epicardium of failing compared with donor hearts (Figure 4D), and 229 
total hERG1a protein trended toward reduction (Figure 4C). In addition, the stoichiometry of the 230 
hERG1a:hERG1b isoforms was altered in failing versus donor hearts, with 0.52- and 0.58-fold reductions 231 
in the endocardium and epicardium, respectively (p = 0.012 and p = 0.019, Figure 4G). Interestingly, 232 
hERG1b did not appear altered in failing hearts (Figure 4E,F); however, there was a trend toward 233 
increased expression of the immature hERG1b isoform in failing hearts (Supplementary Figure S3). 234 
hERG1b data were confirmed by experiments with an alternative antibody and are shown in the 235 





Computer simulation of myocyte IKr blockade. The effects of E-4031 were tested in isolated virtual 240 
nonfailing and failing endocardial myocytes. To simulate the effects of the drug, IKr conductance was 241 
reduced by 90% in nonfailing myocytes and by 90% or 70% in failing myocytes. Based on experimentally 242 
determined protein expression levels, with a stoichiometric shift from hERG1a to hERG1b, we assumed 243 
that the effect of the drug could be weaker in failing myocytes. Homotetrameric hERG1a channels have 244 
differential sensitivity to IKr-blocking drugs compared with hERG1a-hERG1b heteromeric channels, with 245 




The experimentally determined ΔAPD80 shows that the relative APD80 prolongation is greater in 248 
donor compared with failing myocytes. Thus, in order to reproduce experimental results, we carried out 249 
systematic cellular simulations for different PCLs with different degrees of block by E-4031 in nonfailing 250 
and failing myocytes, taking into account HF-induced IKr downregulation (Supplementary Figure S6). 251 
Figure 5A,B show color-coded maps of APD80 prolongation (relative to 100%), which is more 252 
pronounced in the case of nonfailing myocytes for different PCLs and different degrees of drug-induced 253 
block, than in the case of HF with 50% IKr downregulation. Figure 5C shows restitution curves for failing 254 
and nonfailing simulations with or without IKr drug block. Simulated APD80 values at low PCLs are not 255 
reported because of repolarization failure in the HF model. Figure 5D illustrates the corresponding drug-256 
induced APD80 increase with respect to baseline in both failing and nonfailing conditions. Our 257 
simulations qualitatively reproduce experimental results provided that the model of HF includes IKr 258 
remodeling, i.e. a 50% downregulation in the cases illustrated in the two lower curves in Figure 5D. If IKr 259 
downregulation was not included in the HF model, APD80 increase with drug was much more 260 
pronounced than in normal myocytes. These results confirm our hypothesis that IKr is downregulated in 261 
HF, to a similar degree as determined by our experimental protein expression studies. To further 262 
examine the role that other currents play in AP prolongation due to IKr blockade, we repeated 263 
simulations at PCL = 1000 ms, while removing the HF remodeling of other important currents, including 264 
IK1, INa-K, INa,L, and INCX. When these currents were not remodeled, APD80 values were altered before and 265 
after drug block (Figure 5E), thus impacting the ΔAPD80 for each condition (Figure 5F). However, with 266 
the removal of remodeling of any currents in the HF model, ΔAPD80 values were very similar to the HF 267 
model with just 50% IKr reduction. Also, in each case, the ΔAPD80 values are smaller than with the HF 268 
model without IKr downregulation, suggesting that IKr downregulation is key to replicating the 269 
experimental ΔAPD80 trend. 270 
 271 
Multicellular simulation of IKr blockade. The results obtained in the multicellular strand simulations show 272 
a similar tendency: IKr remodeling was required in the HF model to obtain a lesser ΔAPD80 compared 273 
with nonfailing myocytes. Several cases of homogeneous and heterogeneous remodeling were 274 
considered. Figure 6A shows an illustrated schematic of our simulated 1D multicellular strand, with 275 
cones marking the endocardial and epicardial cells, which were used for measurements. Endocardial 276 
(upper panels) and epicardial (lower panels) APs are depicted for baseline and under the effects of E-277 
4031 for nonfailing (Figure 6B,D; cells #50 and #150, respectively) and for failing (Figure 6C,E; cells #50 278 
and #150, respectively). APD prolongation is greater in nonfailing myocytes than in failing myocytes. 279 
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Figure 6F shows nonfailing and failing restitution curves from endocardial and epicardial cells of the 280 
strand with simulated blockade by E-4031. Simulated APD80 values at low PCLs are not reported 281 
because of repolarization failure in the HF model. Note that E-4031 reduces IKr activity by 90% in 282 
nonfailing tissue and by 70% in failing tissue. ΔAPD80 caused by E-4031 is slightly more pronounced in 283 
the nonfailing tissue, as illustrated in Figure 6G. These results corroborate our experimental findings. 284 
Also, the ΔAPD80 values shown are greater in endocardium than in epicardium for both nonfailing and 285 
failing conditions. This effect is intrinsic to basic GPB model (see Figure 7B in Grandi et al.,[14]), where 286 
endocardial cells are more sensitive to IKr block than epicardial cells. In our HF model this effect is even 287 
more evident because IKr downregulation was more pronounced in epicardial cells than in endocardial 288 






Our results demonstrate functional downregulation of the E-4031 sensitive IKr current in the failing 295 
human heart, which may contribute to repolarization abnormalities and arrhythmogenesis in HF. While 296 
we observe a clear functional downregulation of IKr in the failing LV, these changes are not associated 297 
with gene expression changes for hERG1a or hERG1b. We posit that the lack of decreased hERG1a or 298 
hERG1b gene expression suggests transcriptional regulation of IKr is not a homeostatic mechanism in 299 
end-stage human HF, i.e. to preserve contractile force through AP prolongation, and this may contribute 300 
to the relatively small observed APD differences in failing compared with donor human hearts. Although 301 
gene expression is unaltered, we have demonstrated protein expression changes for hERG1a and 302 
hERG1b. Thus, we speculate that post-translational modifications and targeting of hERG channels may 303 
be the most critical factors governing IKr functional expression in failing human heart. Likewise, previous 304 
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studies have demonstrated that cell surface expression of Connexin43 and Cav1.2 are reduced in human 305 
HF due to impaired trafficking.[25, 26] Protein expression levels and post-translational effects on hERG1, 306 
resulting from general disruption in cardiomyocyte architecture and cellular trafficking in HF, are likely 307 
important regulators of IKr levels. 308 
 309 
Alterations of hERG1 expression levels and stoichiometry underlie APD changes. Our results suggest that 310 
functional downregulation may be due to disruption of the cell surface protein expression (mature 311 
hERG1a), with contribution of a stoichiometric shift between hERG1a:hERG1b at the protein level. 312 
Larsen et al.[12] have shown greater levels of hERG1a than hERG1b in the human heart. Thus, 313 
decrements in hERG1a protein may have a greater influence on overall IKr levels. However, the shift in 314 
stoichiometry of hERG1a:hERG1b is due to a reduction in both mature and immature isoforms of 315 
hERG1a, combined with an increased trend in hERG1b.  316 
Though the expression of the hERG1b isoform in the human heart has been somewhat 317 
controversial, with one report showing detection of the hERG1b transcript while another showed no 318 
hERG1b protein expression.[9, 12] However, the most critical demonstration of hERG1b function in the 319 
human heart was from Sale et al.[27], who identified the first long QT-linked mutation specifically within 320 
hERG1b. Our study is the first report of hERG1b in human cardiac tissue at both the transcript and 321 
protein levels; however, we acknowledge the difficulty in obtaining results for hERG1b protein 322 
expression from human cardiac tissue. Often, both hERG1a and hERG1b proteins were difficult to detect 323 
via Western blot. We primarily attribute this to the process for development and validation of 324 
antibodies, which are typically only tested against overexpressed hERG proteins in heterologous 325 
expression systems. Thus, when attempting to probe in human cardiac tissue, the low level of hERG1 326 
protein relative to other cellular proteins makes detection challenging. We attempted to use several 327 
antibodies from various companies including Abcam, Alomone Labs, Cell Signaling Technology, Enzo Life 328 
Sciences, and Santa Cruz Biotechnology. Several of the antibodies yielded considerable non-specific 329 
binding; thus, we did not consider these results to be interpretable or accurate. Ultimately, we observed 330 
the sharpest results for hERG1a and hERG1b expression with the antibody from Alomone Labs, and 331 
confirmed specific hERG1b expression with the hERG1b antibody from Enzo Life Sciences 332 
(Supplementary Figure S4). 333 
 334 
Optical imaging of LV wedge preparations versus an isolated cell approach. In many experimental 335 
systems, whole-cell voltage clamp is the gold standard for measuring functional channel cell surface 336 
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expression,[28-30] and IKr has been successfully recorded in isolated cardiomyocytes from undiseased 337 
human hearts.[31, 32] However, we have not used cell isolation and patch-clamp methods for several 338 
reasons. Delayed-rectifier current levels are small in cardiomyocytes, because these channels operate 339 
on the portion of the AP where membrane resistance is high; thus minor changes in K+ current flux lead 340 
to large changes in membrane potential.[33] The amplitude of representative IKr tail current in human 341 
cardiac myocytes was shown to be ~50 pA, which contrasts with other human cardiac ion currents that 342 
are hundreds of pAs to nAs in amplitude, such as INa or IK1.[31, 32] In addition, the cell isolation process 343 
has been shown to specifically disrupt the membrane expression of delayed rectifier K+ channels. This 344 
effect should be particularly pronounced for the digestion of human myocardium, which requires harsh 345 
digestion conditions due to the high level of fibrotic tissue, especially in failing hearts. Presumably, due 346 
to the combination of these effects, Beuckelmann and colleagues were unable to analyze delayed-347 
rectifier K+ currents in isolated cells from donor or failing hearts. In this study, delayed-rectifier currents 348 
were either small or non-existent, which prohibited comparison between groups.[2, 34] Thus, due to the 349 
relatively small amplitude of IKr in even nondiseased human cardiomyocytes, and the variability in 350 
current amplitude demonstrated by Beuckelmann et al.[2], we concluded that differences IKr between 351 
donor and failing heart populations would be difficult to reliably detect without prohibitively large 352 
sample numbers. 353 
Instead, we have relied on changes in APD following IKr blockade to serve as an indicator for 354 
functional expression. Although the E-4031 blocker utilized is highly specific for IKr, we recognize that our 355 
approach does not completely isolate the effects of this single current on ΔAPD. Cardiac APs are the 356 
composite of dynamic responses from many currents, and, thus, ΔAPDs from blocking IKr cannot be 357 
solely attributed to the density of IKr. Simulation studies using multivariate correlation analysis of ΔAPD 358 
from IKr blockade show that IKr conductance is the most strongly (positively) associated model 359 
parameter, but that many other parameters are also correlated with ΔAPD.[35, 36] These other 360 
parameters include conductances and kinetics of many ion channels, such as IK1, IKs and INa,L, which may 361 
be positively or negatively associated with ΔAPD from IKr blockade. However, the added power of our 362 
approach is the ability to obtain AP recordings from many cells within tissue, and from different 363 
transmural regions; thus, providing additional information that more closely approximates the behavior 364 
in the intact human heart. We also consider the magnitude of the experimental effect to be quite 365 
profound, with ~70% increase in APD80 after IKr blockade in donor compared with only ~30% increase in 366 
failing hearts. This large experimental difference supports that a reduction in IKr conductance is a major 367 
contributing factor to the differential response to IKr blockade in donor versus failing hearts. 368 
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Optical mapping of LV wedge preparations has also enabled us to confirm other aspects of EP 369 
remodeling in the failing human heart that have formerly been reported by our group. We have 370 
previously found transmural gradients in APD to be reduced in failure[3, 4, 23, 37], which we also 371 
observed in this study. In two preparations, we also identified some tissue areas that would have been 372 
labeled as M cell islands by the definition used in Glukhov et al.[23]  373 
 374 
Reduced ΔAPD80s in failing and the Law of Initial Values. Our results also indicate that the reduced 375 
percent increase in APD following IKr blockade is not due to the Law of Initial Value (LIV),[38, 39] which 376 
would assert that the reduced ΔAPD80s in failing are due to higher baseline values. Although, the 377 
underlying mechanism for a LIV effect is unknown, the prolonged APs in failing would be closer to a 378 
theoretical APD upper limit. Following IKr blockade, not only was ΔAPD80 greater for donor hearts, but 379 
also the absolute duration of APs was greater compared with failing hearts, further suggesting 380 
functional IKr downregulation in failure. 381 
 382 
 IKr downregulation in HF computational models. Our computer simulations qualitatively reproduced the 383 
experimental IKr downregulation. As stated above, there was previously no experimental evidence of IKr 384 
downregulation in the failing human heart, and results of delayed rectifier current expression from 385 
animal models of HF are strikingly inconsistent. Tsuji and colleagues found that, in the rabbit pacing-386 
induced HF model, both E-4031-sensitive and -resistant components were significantly smaller than 387 
those in control hearts.[40] In addition, decreased activity of the delayed rectifier current was observed 388 
in ventricular myocytes obtained from cats with hypertrophy.[41] In contrast, studies of isolated 389 
myocytes from the pressure overload guinea pig or spontaneously hypertensive rat models documented 390 
no change in IKr. Likewise, IKr also remained unchanged in canine models of HF.[42] [43, 44] Thus, in 391 
previous simulation studies, IKr downregulation has not been incorporated in computational HF models, 392 
regardless of species.[45-47] Only Walmsley et al.[17] considered IKr downregulation in their HF 393 
computer model on the basis of our group’s previous experimental findings on gene expression changes 394 
in HF.[11] Our simulations illustrate for the first time that IKr downregulation must be incorporated in HF 395 
remodeling to obtain a smaller E-4031-induced APD80 prolongation than in nonfailing conditions, as 396 
obtained experimentally in the present study. 397 
Another aspect shown in our simulations and in previous computational studies, is that IKr block-398 
induced APD prolongation does not only depend on the amount of IKr but also on the amount of other 399 
currents conductance (see Figure 6F). Similarly, a computational study based on Luo and Rudy dynamic 400 
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model (Luo and Rudy 1994) by Saiz et al. (Saiz et al., 2011) obtained different APD prolongations with 401 
the same dose of dofetilide in endocardial, epicardial, and M cells, which present differences in IKs 402 
conductance. Also Brennan et al. (Brennan et al., 2009) used TNNP  (Ten Tusscher 2006) model and 403 
obtained different APD prolongations with sotalol in the different ventricular cells having different Ito 404 
and IKs conductances. Finally, Mirams et al. (Mirams et al., 2011) highlighted the importance of including 405 
three (instead of IKr only) ion-channel effects to the predictive classification of drugs into the risk 406 
categories established by Redfern (Redfern et al., 2003). They suggested that AP modeling of multiple 407 
ion-channel effects may improve early identification of clinical risk and that torsadogenic effects of hERG 408 
block can be eliminated by inhibiting additional channels. Although it is important to take into account 409 
that IKr block-induced APD prolongation is affected by other ion currents, we can conclude from our 410 
simulations that IKr downregulation leads to lower IKr block-induced APD prolongations than in the 411 
absence of IKr downregulation. Indeed, as demonstrated the simulation studies by Britton et al. (Britton 412 
et al., 2013) and Sarkar et al. (Sarkar et al., 2011), IKr conductance is the ionic parameter which affects 413 
the most APD prolongation after drug induced IKr block, much more than other ion channel 414 
conductances. Also the sensitivity analyses performed by O’hara et al. (O’Hara et al., 2011) and 415 
Walmsley et al. (Walmsley et al., 2013) showed that IKr downregulation had a bigger effect on APD 416 
prolongation than remodeling of other ion currents in control conditions. This held for failing myocytes 417 




Our protocol required the use of blebbistatin in order to acquire APs free of motion artifact. 422 
Blebbistatin has been previously shown not to affect electrophysiology in multiple species, including 423 
humans.[48] In addition, because we work with human tissue, we take hearts for study as they become 424 
available; thus, we have a varied and uncontrolled population in comparison to animal models research. 425 
There are other important factors upon which we are unable to perfectly match our donor and failing 426 
heart groups, including age and gender. 427 
Our computer myocyte model for HF, based on changes in the ion channel parameters, has the 428 
inherited limitations described in Trenor et al.[15] Mainly, data from a large number of experimental 429 
studies were taken into account, thus resulting in a high variability not only in the ionic remodeling but 430 
also in the stage and etiology of HF and its phenotype. This computer model was validated against 431 
experimental data of AP and Ca2+ transient measurements in human failing hearts. APD prolongation in 432 
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HF was 43% using the baseline HF model; this value is within the experimental range[45, 49]. In the 433 
present study, when IKr downregulation was also included in the HF model, APD prolongation was more 434 
pronounced (70%). The experimental studies by Beuckelman et al.[2, 50] also reported a pronounced 435 
APD increase (60-67%) in HF.[2, 50] Given the existent experimental variability in HF measurements, 436 
various combinations of ion current remodeling values would yield a HF phenotype within experimental 437 
ranges. In this way, the simulation study by Walmsley et al.[17] considers a polulation of HF models to 438 
account for the experimental variability. 439 
It is also to be noted that the baseline GPB model has an APD80 within experimental ranges taken 440 
from other studies, but significantly shorter than the experimental measurements shown in the present 441 
work.  The absolute APD80 values simulated with our HF model also present significant differences with 442 
our experimental measurements. The comparison between experiments and simulations should not be 443 
strictly quantitative but rather qualitative, given the high experimental variability. We would like to 444 
highlight again that these simulations are a proof of concept rather than a strict reproduction of the 445 
experimental quantitative results. 446 
 In spite of its inherent limitations, the HF model utilized in the present study provides valid proof-447 





Figure Legends 453 
 454 
Figure 1. Experimental methodology. A. Posterolateral image of a human heart. Black dashed box 455 
outlines marginal artery territory for wedge preparation, and black arrowheads indicate two descending 456 
marginal arteries. B. Representative wedge preparation image with paired optical (blue) and 457 
microelectrode (red) recordings. Wedge transmural regions separated by dashed lines, and black and 458 
red arrows highlight pacing and microelectrodes, respectively. C. Timeline of the experimental protocol. 459 
A=aorta; Epi=epicardium; Endo=endocardium; LA=left atrium; LV=left ventricle; RA=right atrium; 460 
RV=right ventricle. 461 
 462 
Figure 2. APD80 restitution before and after IKr blockade. Restitution curves for the pacing cycle length 463 
(PCL) versus APD80 for A. donor (n=7) and D. failing (n=4) hearts at baseline, demonstrating greater 464 
transmural APD80 dispersion for donor hearts and higher APD80s for failing hearts. APD80 restitution 465 
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curves for B. donor and E. failing hearts after IKr blockade with E-4031. In contrast to the baseline 466 
conditions, absolute APD80 values are now greater in donor compared with failing hearts. APD80 467 
gradients (APD80Endo – APD80Epi) at several PCLs for C. baseline and F. E-4031 conditions. Data are 468 
expressed as mean ± SEM. 469 
 470 
Figure 3. ΔAPD80 values with IKr blockade. A-B. Representative APD80 maps, optical recording traces, 471 
and pseudo-ECGs for donor and failing hearts. Gaussian distribution curves calculated from means and 472 
pooled standard deviations of APD80 values for C. donor and D. failing hearts. E. Average APD80 values 473 
for donor (n=7) and failing (n=4) hearts under control and E-4031 conditions recorded at 1000 ms pacing 474 
cycle length (PCL). F. ΔAPD80s, expressed as a % of control for 1000 ms PCLs. Data are expressed as 475 
mean ± SEM. 476 
 477 
Figure 4. hERG1 gene and protein expression levels. Graphs with individual data points showing 478 
hERG1a A. and hERG1b B. gene expression is not different between donor (n=8) and failing (n=8) human 479 
hearts. Box and whisker plots of total hERG1a C. and mature hERG1a D. relative to GAPDH show that 480 
failing (n=5) compared with donor (n=6) heart hERG1a levels trend toward reduction. Graphs 481 
demonstrating total E. and mature F. hERG1b protein expression levels are unchanged. G. Graph 482 
showing significantly decreased hERG1a:hERG1b protein in the failing epicardium. H. Representative 483 
Western blot image. Bar graphs show data expressed as mean ± SEM. Boxes show median, 25% 484 
percentile, and 75% percentile, and whiskers indicate the minimum and maximum of the distribution. 485 
 486 
Figure 5. Cellular simulation results. A,B. Color-coded maps of APD increase (relative to 100%) in 487 
nonfailing myocytes and failing myocytes with IKr blockade. The results are shown for different pacing 488 
cycle lengths (PCLs, x-axis) and for different degrees of drug block (y-axis). The model of HF considers IKr 489 
downregulation by 0.5. C. APD80 restitution curves for nonfailing, failing, and failing with IKr 490 
downregulation myocytes with and without IKr blockade. D.ΔAPD80s with IKr blockade (90% or 70%), 491 
expressed as a % of control in a nonfailing cell and in failing cells with or without IKr downregulation. E. 492 
APD80 values plus and minus IKr blockade for failing cells with and without IKr downregulation at PCL = 493 
1000 ms. Baseline APD80 values and values after removal of HF remodeling for IK1, INa-K, INa,L, and INCX are 494 
displayed. F. ΔAPD80s after IKr blockade for failing myocytes with and without IKr downregulation are 495 




Figure 6. Multicellular strand simulations. A. Illustrated schematic of the multicellular strand for 499 
simulations, including endocardial and epicardial cells and cones marking the cells used for 500 
measurement. B. Nonfailing and C. failing endocardial myocyte APs before and after IKr blockade with E-501 
4031 (cell #50). D. Nonfailing and E. failing epicardial myocytes APs before and after IKr blockade with E-502 
4031 (cell #150). F. APD80 restitution curves of cells #50 (endocardium) and #150 (epicardium) for 503 
nonfailing and failing conditions. Drug blockade was 90% in nonfailing cells and 70% in failing cells. G. 504 
ΔAPD80s expressed as a % of control in cells #50 (endocaridum) and #150 (epicardium) for nonfailing 505 
and failing conditions under IKr blockade with E-4031. Drug blockade was 90% in nonfailing cells and 70% 506 
in failing cells. 507 
 508 
Table 1. Demographic characteristics of donor and failing hearts used for optical imaging analysis. 509 
CVA=cerebrovascular accident; D=donor; F=failing; ICH=intracerebral hemorrhage; ICM=ischemic 510 
cardiomyopathy; MVA=motor vehicle accident; NICM=nonischemic cardiomyopathy. 511 
 512 
D/F Age Gender 
Diagnosis/       
Cause of Death 
D 17 F MVA 
D 37 F CVA 
D 39 M ICH 
D 52 M MVA 
D 58 M CVA 
D 60 M CVA 
D 65 M CVA 
F 44 F NICM 
F 55 M ICM 
F 57 M ICM 
F 59 F NICM 
 22 
 513 
Table 2. Detailed ionic current modifications to GPB model for failing cardiac myoctes. These model 514 




% of change respect original  
GPB model[14] 
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